Concurrent Investment Advisors LLC raised its stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 19.9% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 51,650 shares of the medical research company

Amgen stock is trading close to its 52-week high in early September 2026 as investors respond to rai

Amgen stock is trading just below its 52-week high after double-digit revenue growth and higher 2026

Amgen stock is trading close to its recent 52-week high as of early September 2026, supported by a s

Amgen stock is trading close to its 52-week high after a Q2 2026 earnings beat and new Repatha cardi

Susquehanna Fundamental Investments LLC bought a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 19,066 shares of the medical research company

Amgen stock is trading above $430 after a Q2 2026 earnings beat and higher full-year guidance sharpe

Amgen stock is holding above $430 after Q2 2026 results delivered a clear earnings and revenue beat

Amgen reported Phase 3 VESALIUS-CV data showing Repatha reduced death risk by 20% and lowered cardiovascular events in high-risk adults.